๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Pancreatic Cancer
Clinical trial register · China

Pancreatic Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 9 Jiaxing 2 Ningbo 2
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai9 Jiaxing2 Ningbo2
All 3 locations
Target enrolment
to

Pancreatic Cancer trials in China

9 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
AI-Powered Precision Decision-Making for Pancreatic Diseases
NCT07439757Pancreatic Cancer, Diagnose Disease, IPMN, Pancreatic, Pancreatic Cystic Lesions
Changhai Hospital
Observational
2,000
Shanghai
2026-03-01
Recruiting
CAR-NK Cells (CL-NK-003) in Pancreatic Cancer
NCT07425483Pancreatic Cancer
Changhai Hospital
Phase 1
9
Shanghai
2026-02-12
Recruiting
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
NCT07117045Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, High-grade Pancreatic Intraepithelial Neoplasia, PDAC - Pancreatic Ductal Adenocarcinoma
Changhai Hospital
Observational
400,000
Shanghai, Jiaxing, Ningbo
2025-08-15
Recruiting
CAR-NK Cells (CL-NK-001) in Pancreatic Cancer
NCT06816823Pancreatic Cancer
Changhai Hospital
Phase 1
30
Shanghai
2025-04-07
Recruiting
Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)
NCT06427447Pancreatic Cancer
Changhai Hospital
Phase 3
770
Shanghai
2024-08-06
Recruiting
AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
NCT06638866Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraepithelial Neoplasias, Intraductal Papillary Mucinous Neoplasm
Changhai Hospital
Observational
5,000
Shanghai, Jiaxing, Ningbo
2024-08-03
Recruiting
Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)
NCT06427460Pancreatic Cancer
Changhai Hospital
Phase 2
67
Shanghai
2024-05-12
Recruiting
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer
NCT04146298Pancreatic Cancer, Pancreatic Neoplasms, Pancreatic Ductal Adenocarcinoma, Advanced Cancer
Changhai Hospital
Phase 1/2
30
Shanghai
2021-10-21
Recruiting
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
NCT04743479Pancreatic Cancer, Diabetes, Familial Pancreatic Cancer, Pancreatic Cystic Neoplasm
Changhai Hospital
Observational
5,000
Shanghai
2020-12-01
Rows per page Showing 1–9 of 9
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/condition/pancreatic-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 9 of those studies listing the condition Pancreatic Cancer that also match the filters currently applied.

How many Pancreatic Cancer trials are recruiting in China?

9 of the 9 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Pancreatic Cancer), 9 studies
PhaseStudiesRecruitingShare
Observational4444.4%
Phase 12222.2%
Phase 1/21111.1%
Phase 21111.1%
Phase 31111.1%

Most active sponsors

Lead sponsors with the most studies (Pancreatic Cancer)
Lead sponsorStudiesRecruiting
Changhai Hospital99
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.